Javara and Ogden Clinic Launch Trial Access Partnership
Javara and Ogden Clinic have announced the launch of a partnership to integrate industry-sponsored clinical trials at the point of care for Ogden Clinic patients. Through this partnership, Javara will enable access to clinical trials for patients throughout the Ogden Clinic network by providing services to support and conduct research. The Ogden Clinic currently spans 20 locations in northern Utah and includes 171 practitioners across 24 specialties.
Javara will embed clinical research infrastructure and site staff, led by Javara’s Clinical Trial Navigators, who will work alongside the practitioners and medical staff to scale clinical trial operations. Javara and Ogden Clinic anticipate early clinical trials in general medicine, pediatrics, and dermatology, with initial trials expected to begin in 4th quarter of 2021.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
